Generics 26

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Dexmedetomidine manufacturers

26 products found

Filters

26 products found

dexmedetomidine

Bags for injection/infusion 4 μg/ml - 100 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Australia , Belgium , France , Germany , Italy , Netherlands , Poland , Portugal , South Africa , Spain , United Kingdom , Vietnam
Registered in
Austria , Belgium , France , Germany , Italy , Netherlands , Poland , Portugal , Spain , United Kingdom
Available for
Licensing with supply, Distribution only
Comments
Shelf life: Polypropylene bags - 2 years; PVC-free polyolefin bags - 21 months
Manufacturer #15084

Manufacturer usually replies in 18 days

dexmedetomidine

Vials, injection 0.1 mg - 2 ml, 4 ml, 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Algeria , Bahrain , Canada , Chile , Egypt , Iran , Iraq , Israel , Jordan , Kazakhstan , Kuwait , Lebanon , Libya , Malaysia , Mexico , Morocco , Oman , Qatar , Russia , Saudi Arabia , South Africa , Sudan , Syria , Tunisia , Ukraine , United Arab Emirates , Vietnam , Yemen
Comments
Storage below +30 C
Manufacturer #1586
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe, the Middle East, CIS, LATAM, and Asia for 10+ years. The company's production lines are GMP-compliant. Main dosage forms include solid, liquid, and injection. The company prepares dossier in EU CTD format.

Manufacturer usually replies in 6 days

dexmedetomidine

Concentrate for solution for infusion 100 µg/ml - 2 ml, 4 ml, 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Comments
Ref: Dexdor®
Manufacturer #10720

It is one of the oldest pharmaceutical companies specializing in generic mostly for the hospital segment. The key products offered are life-saving medicines, especially in the CNS and cardiovascular therapeutic group. The company follows and complies with the EU GMP requirements.

Manufacturer usually replies in 4 days

dexmedetomidine

Concentrate for injection/infusion solution 200 mcg/2 ml, 400 mcg/4 ml, 1000 mcg/10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Kazakhstan , Russia , Saudi Arabia , United Arab Emirates
Available for
Distribution only
Manufacturer #12922

Manufacturer usually replies in 7 days

dexmedetomidine

Bags for injection/infusion 4 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Precedex®Pfizer
Manufacturer #8822
A pharmaceutical manufacturer based in Europe that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, and Asia for 50+ years. The main therapeutic areas include CNS, ophthalmology, and dermatology. Main dosage forms include sterile and solid oral dosage forms. The company's production lines are cGMP-compliant. The company possesses branches in Europe, North America, and Asia.

Manufacturer usually replies in 5 days

dexmedetomidine

Vials 100 mcg/mL - 4 ml, 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Belarus , Russia
Available for
Licensing with supply
Comments
DCP submitted
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

dexmedetomidine

Vials, injection 100 mcg/ml - 2 ml, 4 ml, 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Austria , Belgium , France , Germany , Italy , Netherlands , Poland , Portugal , South Africa , United Kingdom , Vietnam
Registered in
Austria , Belgium , France , Germany , Italy , Netherlands , Poland , Portugal , Spain , United Kingdom
Manufacturer #15084

Manufacturer usually replies in 18 days

dexmedetomidine

Ampoules, injection 100 mcg/ml - 2 ml, 4 ml, 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Austria , Belgium , France , Germany , Italy , Netherlands , Poland , Portugal , South Africa , United Kingdom , Vietnam
Registered in
Austria , Belgium , France , Germany , Italy , Netherlands , Poland , Portugal , Spain , United Kingdom
Available for
Licensing with supply
Manufacturer #15084

Manufacturer usually replies in 18 days

dexmedetomidine

Solution for injection 100 mcg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #5525

dexmedetomidine

Vials, injection 100 mcg/ml - 2 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
EU GMP
Unavailable markets
Philippines
Available for
Licensing with supply, Distribution only
Manufacturer #559

Manufacturer usually replies in 8 days

dexmedetomidine

Solution for injection 100 mcg/ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA
Manufacturer #5525

dexmedetomidine

Ampoules, injection 100 mg/ml - 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
Ukraine
Unavailable markets
Tajikistan , Ukraine , Uzbekistan
Registered in
Tajikistan , Ukraine , Uzbekistan
Available for
Licensing with supply, Distribution only
Manufacturer #13610
A pharmaceutical manufacturer based in Europe that is selling its products in 10+ countries in Europe and CIS for 50+ years. Key production lines are Rx and medical devices. The company's production lines are EU GMP-compliant. Main therapeutic areas include antibacterial, antiviral, and antituberculosis.

Manufacturer usually replies in 3 days

dexmedetomidine

Ampoules 100 mg/ml - 2 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
Comments
DCP submitted
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

dexmedetomidine

Injection 4 mcg/ml, 100 mcg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #10627

Manufacturer usually replies in 9 days

dexmedetomidine

Solution for injection 100 mcg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Available for
Licensing with supply
Manufacturer #15910

Manufacturer usually replies in 12 days

dexmedetomidine

Injection 100 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
FDA
Manufacturer #20781
The vision of the company is to develop and promote local expertise in the pharmaceutical industry. With the mission of quality medicines, health, and well-being of people and the environment. They manufacture and market high-quality branded generics in more than 40 countries across the globe.

Manufacturer usually replies in 9 days

dexmedetomidine

Injection, pre-filled syringe 100 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

dexmedetomidine

Injection 50 mcg, 100 mcg, 200 mcg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20368

Manufacturer usually replies in 8 days

dexmedetomidine

Injection 200 µg/2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
COFEPRIS
Manufacturer #18736
It was founded in the 2000s. The main aim of the position itself in the market as a company dedicated to the research, development, manufacturing, marketing, and distribution of new generation specialized generic and biosimilar medicines.

Manufacturer usually replies in 7 days

dexmedetomidine

Injection 50 mcg / 0.5 ml, 100 mcg / 1 ml, 200 mcg / 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17417

Manufacturer usually replies in 6 days

Want to view all 26 products? Create your free account today!

What is DEXMEDETOMIDINE?

Dexmedetomidine is a generic pharmaceutical drug that is applied as an adjuvant for premedication, exceptionally in victims susceptive to preoperative and perioperative stress because of its tranquilizer, anxiolytic, analgesic, sympatholytic, and stable hemodynamic silhouette. The antagonistic influences of dexmedetomidine incorporate hypotension, nausea, bradycardia, atrial fibrillation, and hypoxia- which are the common side effects. Overdose produce causes a first-degree or second-degree atrioventricular stone.

How Does DEXMEDETOMIDINE Work?

This pharmaceutical drug has 2 sites of action. It arouses presynaptic α2-adrenoceptors, therefore frustrating the announcement of norepinephrine and hence the circulation of pain flags. It additionally operates postsynaptically to produce a contraction in blood tension and pacemaker rate.

The Wholesale Price of DEXMEDETOMIDINE

An online search for the wholesale price of DEXMEDETOMIDINE will reveal a wide range of costs. The price for dexmedetomidine intravenous enzyme (4 mcg/mL-NaCl 0.9%) is $228 for a quantity of 200 milliliters, depending on the drugstore you attend.

DEXMEDETOMIDINE Manufacturers and Suppliers

We have found 28 verified dexmedetomidine manufacturers and dexmedetomidine suppliers from our global list of sellers. The pharmaceutical drug is available for sale in different forms such as bags, ampoules, vials, solution for injection, concentrate for solution for injection/infusion, injection, solution for infusion from manufacturers in various countries including European Union, India, South Korea, Indonesia.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of dexmedetomidine offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for dexmedetomidine manufacturers and dexmedetomidine suppliers that you are looking for. These also enable you to check the dossier status of dexmedetomidine, and the GMP approvals of the different variants of dexmedetomidine. Also, each manufacturer or supplier product description contains essential information about dexmedetomidine including clinical data, stability zones, countries where dexmedetomidine is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over dexmedetomidine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering processes. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that dexmedetomidine manufacturers have, we qualify their companies before they are on-boarded on the platform. This allows us to screen dexmedetomidine manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.